Publications: Dr Ruth Dobson

Watson N, Moullaali T, Casado A, McAuley S, McDonald J, Smith C, Dobson R, Davenport R ( 2025 ) . Headache and progressive visual loss . Practical Neurology

Bove R, Oreja-Guevara C, Vukusic S, Shah A, Graham E, McElrath T, Pietrasanta C, Dobson R et al. ( 2025 ) . Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and the Potential Impact on B-Cell Levels: Primary Analysis of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO (PL4.004) . Neurology vol. 104 , ( 7_Supplement_1 )

Vukusic S, Bove RM, Hellwig K, Krysko K, Pasquarelli N, Oreja-Guevara C, Dobson R ( 2025 ) . Impact sur la grossesse et le nouveau-né de l’utilisation d’ocrelizumab (OCR) chez les femmes atteintes de sclérose en plaques (SEP) : analyse d’environ 3000 grossesses . Revue Neurologique vol. 181 ,

Vukusic S, Hellwig K, Bove RM, Oreja-Guevara C, Dobson R, Maillart E, Jacobs D ( 2025 ) . Lymphocytes B (LB) chez le nourrisson, transfert placentaire et réponses humorales maternelles pendant la grossesse sous ocrelizumab (OCR) : analyse de l’étude de phase IV, en ouvert, multicentrique, prospective MINORE . Revue Neurologique vol. 181 , s144 - s145 .

Vukusic S, Hellwig K, Bove RM, Oreja-Guevara C, Dobson R, Shah A, Graham E ( 2025 ) . Lymphocytes B (LB) chez les nourrissons de femmes allaitantes atteintes de sclérose en plaques (SEP) recevant Ocrelizumab (OCR) : résultats de l’étude SOPRANINO . Revue Neurologique vol. 181 ,

Mah H, Thomson A, Dobson R ( 2025 ) . The Importance of Lived Experience: A Scoping Review on the Value of Patient and Public Involvement in Health Research . Health Expectations

Zabihi S, Bestwick JP, Jitlal M, Bothongo PL, Zhang Q, Carter C, Roche M, Morgan‐Trimmer S et al. ( 2025 ) . Early presentations of dementia in a diverse population . Alzheimer's & Dementia vol. 21 , ( 2 )

Platt IS, Joseph A, Tsirka V, Raja N, Garcia M, Palace J, Dobson R ( 2025 ) . Multiple autoimmunity: neuromyelitis optica spectrum disorder with Lambert-Eaton myasthenic syndrome . Practical Neurology

Dobson R, Kenten C, Brown J, Giebel C, Banerjee S, Cooper C ( 2025 ) . Moving towards meaningful patient and public engagement . Nature Reviews Neurology1 - 2 .

Brownlee WJ, Dobson R ( 2025 ) . Navigating pregnancy in women with NMOSD in the monoclonal antibody era . Multiple Sclerosis Journal vol. 31 , ( 5 ) 617 - 618 .

Mullan G, Hughes S, Rog D, Brex P, Dobson R ( 2025 ) . Assisted reproduction technology in multiple sclerosis . Practical Neurology

Paris A, Amirthalingam G, Karania T, Foote IF, Dobson R, Noyce AJ, Marshall CR, Waters S ( 2025 ) . Depression and dementia: interrogating the causality of the relationship . Journal of Neurology Neurosurgery & Psychiatry

Walbaum M, Madhukar A, Dobson R, Cyhlarova E, Castro-Aldrete L, Santuccione Chadha A, Knapp M ( 2025 ) . Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis . Journal of Neurology vol. 272 , ( 1 )

Zabihi S, Bestwick JP, Bothongo PLK, Zhang Q, Carter C, Roche M, Morgan‐Trimmer S, Birks Y et al. ( 2025 ) . Early presentations of dementia across cultures: Analysis of primary care data from a diverse population . Alzheimer's & Dementia vol. 20 , ( Suppl 3 ) e086108 - e086108 .

Vukusic S, Bove R, Dobson R, McElrath T, Oreja-Guevara C, Pietrasanta C, Lin C-J, Ferreira G et al. ( 2024 ) . Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab . Neurology Neuroimmunology & Neuroinflammation vol. 12 , ( 1 )

Chen B, Francis A, Cooper SA, Dobson R, Hacohen Y, Halfpenny C, Hemingway C, Hobart JC et al. ( 2024 ) . Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder . Neurology vol. 104 , ( 1 )

Hellwig K, Oreja-Guevara C, Dobson R, Vukusic S, Shah A, Graham E, McElrath T, Pietrasanta C et al. ( 2024 ) . 175. B-cell Levels in Infants of Lactating Women with Multiple Sclerosis Receiving Ocrelizumab: SOPRANINO Primary Results . Multiple Sclerosis and Related Disorders vol. 92 ,

Dobson R, Vukusic S, Bove R, Hellwig K, Krysko K, Pietrasanta C, McElrath T, Craveiro L et al. ( 2024 ) . 176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date . Multiple Sclerosis and Related Disorders vol. 92 ,

Hellwig K, Bove R, Oreja-Guevara C, Dobson R, Maillart E, Jacobs D, McElrath TF, Pietrasanta C et al. ( 2024 ) . 178. B-cell Levels and Placental Transfer in Infants Potentially Exposed to Ocrelizumab During Pregnancy: Primary Analysis of the Prospective Multicentre, Open-label Phase IV MINORE study . Multiple Sclerosis and Related Disorders vol. 92 ,

Pace S, Messina S, Chen B, Tanasescu R, Papathanasiou A, Constantinescu CS, Leite MI, Willis MD et al. ( 2024 ) . Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series . European Journal of Neurology vol. 32 , ( 1 )

Rashid W, Ciccarelli O, Leary SM, Arun T, Doshi A, Evangelou N, Ford HL, Hobart J et al. ( 2024 ) . Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance . Practical Neurology vol. 25 , ( 1 ) 18 - 24 .

Arun T, Petheram K, Tallantyre E, Ford H, Chataway J, Mac Dougall N, Doshi A, Englezou C et al. ( 2024 ) . Assessing the landscape and charting paths: UK neurology trainees’ opinions on neuroinflammation subspecialty . Multiple Sclerosis and Related Disorders vol. 92 ,

Jacobs BM, Stow D, Hodgson S, Zöllner J, Samuel M, Kanoni S, Bidi S, Walter K et al. ( 2024 ) . Genetic architecture of routinely acquired blood tests in a British South Asian cohort . Nature Communications vol. 15 , ( 1 )

Amezcua L, Rotstein D, Shirani A, Ciccarelli O, Ontaneda D, Magyari M, Rivera V, Kimbrough D et al. ( 2024 ) . Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia . The Lancet Neurology vol. 23 , ( 10 ) 1050 - 1062 .

Jacobs BM, Schalk L, Tregaskis-Daniels E, Tank P, Hoque S, Peter M, Tuite-Dalton K, Witts J et al. ( 2024 ) . The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study . Multiple Sclerosis Journal vol. 30 , ( 11-12 ) 1544 - 1555 .

Francis A, Santos M, Leal Rato M, Wintle YM, Brex P, Chen B, Cooper S, Dobson R et al. ( 2024 ) . Study of seasonality of attacks in MOG antibody-associated disease . Multiple Sclerosis and Related Disorders vol. 90 ,

Zaloum SA, Mahesh M, Cetin MA, Ganesh S, Horne R, Giovannoni G, Dobson R ( 2024 ) . Diversity and representation within the literature on sexual dysfunction in multiple sclerosis: A systematic review . Multiple Sclerosis and Related Disorders vol. 89 ,

De Dios Perez B, Pritchard C, Powers K, das Nair R, Evangelou N, Ford H, Tallantyre E, Dobson R et al. ( 2024 ) . The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multiple Methods Study . International Journal of MS Care vol. 26 , ( Q3 ) 174 - 186 .

Petheram K, Dobson R ( 2024 ) . All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary . Multiple Sclerosis Journal vol. 30 , ( 9 ) 1111 - 1112 .

Zhang Q, Noyce AJ, Robson J, Giovannoni G, Marshall CR, Dobson R ( 2024 ) . No association between oral contraceptive exposure and subsequent MS: A population-based nested case–control study in primary care . Multiple Sclerosis Journal vol. 30 , ( 9 ) 1221 - 1226 .

Dobson R, Patterson K, Malik R, Mandal U, Asif H, Humphreys R, Payne M, O-Charoenrat E et al. ( 2024 ) . Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 95 , ( 9 ) 796 - 803 .

Devine H, Jabbari E, Scott J, Mehta AR, Dobson R, Mead S ( 2024 ) . Academic neurology in the UK: a plea to turn away from the precipice . Brain vol. 147 , ( 7 ) 2270 - 2273 .

Gklinos P, Dobson R ( 2024 ) . Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management . Antibodies vol. 13 , ( 2 )

Patyjewicz M, Mair D, Zaloum SA, Onen B, Walton J, Dobson R, Joerres C, Shah AM et al. ( 2024 ) . Recreational nitrous oxide and thrombotic events: a case series . BMJ Neurology Open vol. 6 , ( 1 )

Bove R, Pietrasanta C, Oreja-Guevara C, Hellwig K, Dobson R, Vukusic S, Lin C-J, Alvarez DGP et al. ( 2024 ) . Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004) . Neurology vol. 102 , ( 7_supplement_1 )

Tallantyre EC, Dobson R, Froud JLJ, St John FA, Anderson VM, Arun T, Buckley L, Evangelou N et al. ( 2024 ) . Real‐world persistence of multiple sclerosis disease‐modifying therapies . European Journal of Neurology vol. 31 , ( 7 )

Vukusic S, Hellwig K, Oreja-Guevara C, Pietrasanta C, McElrath TF, Dobson R, Bove RM ( 2024 ) . Données de grossesses et des enfants de femmes recevant ocrelizumab pour le traitement de la sclérose en plaques : analyse de la plus grande base de données disponible . Revue Neurologique vol. 180 ,

Kuri A, Henshall DE, Chaudhry D, Ooi SZY, Zhang Q, Mathews J, Thomson A, Rog D et al. ( 2024 ) . Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland . BMC Neurology vol. 24 , ( 1 )

Leal Rato M, Chen B, Francis A, Messina S, Miron M, Sharawakanda Y, O'Sullivan E, Cooper S et al. ( 2024 ) . A study of referral bias in NMOSD and MOGAD cohorts . Multiple Sclerosis and Related Disorders vol. 85 ,

Nasir M, Hone L, Tallantyre E, Kelly P, Leite MI, Robertson N, Bestwick J, Huda S et al. ( 2024 ) . Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder . Multiple Sclerosis and Related Disorders vol. 85 ,

Thomson A, Stennett A, Metin C, Bestwick J, Giovannoni G, Dobson R ( 2024 ) . Under & Over: A randomised controlled study to develop an upper limb rehabilitation tool for people with Multiple Sclerosis . Multiple Sclerosis and Related Disorders vol. 85 ,

Jacobs BM, Vickaryous N, Giovannoni G, Proitsi P, Waters S, Dobson R ( 2024 ) . Plasma proteomic profiles of UK Biobank participants with multiple sclerosis . Annals of Clinical and Translational Neurology vol. 11 , ( 3 ) 698 - 709 .

Foote IF, Bandres‐Ciga S, Kim JJ, Alvarado CX, Leonard HL, Bothongo PL, Grotzinger AD, Jacobs BM et al. ( 2023 ) . A Multivariate Genome‐Wide Association Study of the Shared Genetic Architecture Among Modifiable Risk Factors for Dementia: 590 Loci Associated with Brain Health . Alzheimer's & Dementia vol. 19 , ( S22 )

Dobson R ( 2023 ) . A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis . Multiple Sclerosis Journal

Hellwig K, Oreja-Guevara C, Vukusic S, Pietrasanta C, Mcelrath T, Dobson R, Craveiro L, Ferreira G et al. ( 2023 ) . Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database . Multiple Sclerosis and Related Disorders vol. 80 ,

Bernard Healey SA, Giovannoni G, Noyce A, Dobson R, Jacobs BM ( 2023 ) . Impact of multiple sclerosis risk alleles on the plasma proteome . Brain vol. 147 , ( 2 ) e17 - e21 .

Jacobs BM, Tank P, Bestwick JP, Noyce AJ, Marshall CR, Mathur R, Giovannoni G, Dobson R ( 2023 ) . Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort . Journal of Neurology vol. 271 , ( 1 ) 241 - 253 .

Leddy S, Dobson R ( 2023 ) . Multiple sclerosis . Medicine vol. 51 , ( 9 ) 637 - 644 .

Liu C, Pace S, Bromley R, Dobson R ( 2023 ) . Exposure to medication for neurological disease in pregnancy – time to consider the long-term implications? . EClinicalMedicine vol. 63 ,

Fan JH, Alexander J, Poole S, Wijangco J, Henson LJ, Dobson R, Guo C-Y, Bove R ( 2023 ) . Characteristics of multiple sclerosis and demyelinating disease in an Asian American population . Multiple Sclerosis Journal vol. 29 , ( 10 ) 1216 - 1228 .

Dobson R, Ovadia C, Mathews J, Brex P ( 2023 ) . Prescribing in pregnancy: navigating risks and benefits . Practical Neurology vol. 23 , ( 5 ) 366 - 367 .

Chen B, Gomez‐Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, Messina S, Sa M et al. ( 2023 ) . Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD? . Annals of Neurology vol. 94 , ( 3 ) 508 - 517 .

Dobson R ( 2023 ) . Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination . Multiple Sclerosis Journal

Lee CD, Galetta SL, Dobson R ( 2023 ) . Management of Possible Multiple Sclerosis . New England Journal of Medicine vol. 388 , ( 23 ) 2195 - 2198 .

Dobson R, Jacobs B ( 2023 ) . Early depressive symptoms and disability accrual in Multiple Sclerosis - a UK MS Register study . Scientific Reports

Gklinos P, Dobson R ( 2023 ) . Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide . Pharmaceuticals vol. 16 , ( 5 )

Jacobs BM, Schalk L, Dunne A, Scalfari A, Nandoskar A, Gran B, Mein CA, Sellers C et al. ( 2023 ) . ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK . BMJ Open vol. 13 , ( 5 )

Fan J, Alexander J, Poole S, Wijangco J, Henson L, Dobson R, Guo C-Y, Bove R ( 2023 ) . Characteristics of Multiple Sclerosis and Demyelinating Disease in an Asian American Population (P9-3.009) . Neurology . vol. 100 ,

Bove R, Amato MP, Dobson R, Krysko KM, Stoll S, Vukusic S, Yamout B, Zielman R et al. ( 2023 ) . Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database (P9-3.014) . Neurology . vol. 100 ,

Oreja-Guevara C, Vukusic S, Pietrasanta C, Mcelrath TF, Hellwig K, Bove RM, Dobson R ( 2023 ) . Données de grossesses et des enfants de femmes recevant ocrélizumab pour le traitement de la sclérose en plaques . Revue Neurologique vol. 179 ,

Dobson R ( 2023 ) . Family planning and multiple sclerosis . The Lancet Neurology

Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M et al. ( 2023 ) . Family planning considerations in people with multiple sclerosis . The Lancet Neurology vol. 22 , ( 4 ) 350 - 366 .

Dobson R, Jacobs B, Marshall C ( 2023 ) . Polygenic risk score prediction of Multiple Sclerosis in individuals of South Asian ancestry . Brain Communications

Dobson R ( 2023 ) . Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease . British Journal of Neuroscience Nursing

Dobson R ( 2023 ) . Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis (MS) during pregnancy and breastfeeding: a systematic review and Delphi consensus . Multiple Sclerosis Journal

Teelucksingh S, Govind RM, Dobson R, Nelson-Piercy C, Ovadia C ( 2023 ) . Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations . International Journal of Women's Health vol. 15 , ( 0 ) 321 - 338 .

Dobson R, Rehill N, Weil RS ( 2023 ) . Democratising access to dementia research . Advances in Clinical Neuroscience & Rehabilitation vol. 22 , ( 3 ) 12 - 15 .

Noyce A ( 2022 ) . The association between anti-epileptic drugs and incident Parkinson’s disease in UK Biobank . JAMA Neurology

Dreyer-Alster S, Achiron A, Giovannoni G, Jacobs BM, Dobson R ( 2022 ) . No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study . Scientific Reports vol. 12 , ( 1 )

Iyer P, Dobson R ( 2022 ) . Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies . Neurology and Therapy vol. 12 , ( 1 ) 1 - 10 .

Hartmann M, Fenton N, Dobson R ( 2022 ) . Development of Bayesian Network for Multiple Sclerosis Risk Factor Interaction Analysis . Computational Intelligence Methods for Bioinformatics and Biostatistics , vol. 13483 , Springer Nature

Dobson R ( 2022 ) . Social determinants of health and their impact in multiple sclerosis . Nature Reviews Neurology

Kuri A, Vickaryous N, Awad A, Jacobs BM, Dobson R ( 2022 ) . Vitamin D genetic risk scores in multiple sclerosis . Journal of Neurology vol. 270 , ( 2 ) 1030 - 1035 .

Dobson R, Bove R ( 2022 ) . In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk . Neurology vol. 99 , ( 17 ) 737 - 738 .

Jacobs BM, Peter M, Giovannoni G, Noyce AJ, Morris HR, Dobson R ( 2022 ) . Towards a global view of multiple sclerosis genetics . Nature Reviews Neurology vol. 18 , ( 10 ) 613 - 623 .

Simpson-Yap S, Pirmani A, Kalincik T, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N et al. ( 2022 ) . Updated Results of the COVID-19 in MS Global Data Sharing Initiative . Neurology Neuroimmunology & Neuroinflammation vol. 9 , ( 6 )

Dobson R, Bove R ( 2022 ) . In Vitro Fertilization and Multiple Sclerosis . Neurology vol. 99 , ( 17 ) 737 - 738 .

Simpson-Yap S, Pirmani A, De Brouwer E, Peeters LM, Geys L, Parciak T, Helme A, Hillert J et al. ( 2022 ) . Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β . Multiple Sclerosis and Related Disorders vol. 66 ,

Dobson R, Tanasescu R, Gran B ( 2022 ) . Editorial: Preventing multiple sclerosis . Frontiers in Neurology vol. 13 ,

Dobson R, Rog D, Ovadia C, Murray K, Hughes S, Ford HL, Pearson OR, White S et al. ( 2022 ) . Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines . Practical Neurology vol. 23 , ( 1 ) 6 - 14 .

Dobson R ( 2022 ) . Preventing Multiple Sclerosis - from evidence to action . Frontiers in Neurology

K A-P, A S, T B, AC J, A M, S G, R D, G G et al. ( 2022 ) . Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 65 ,

Rivas C, Anand K, Wu AF-W, Goff L, Dobson R, Eccles J, Ball E, Kumar S et al. ( 2022 ) . Lessons From the COVID-19 Pandemic to Improve the Health, Social Care, and Well-being of Minoritized Ethnic Groups With Chronic Conditions or Impairments: Protocol for a Mixed Methods Study . JMIR Research Protocols vol. 11 , ( 7 )

Judge-Clayden F, Iyer P, Williams A, Murray K, Dobson R ( 2022 ) . Multiple sclerosis, disease modifying therapies and pregnancy . British Journal of Neuroscience Nursing vol. 18 , ( Sup3 ) s22 - s26 .

Bove R, Hellwig K, Pasquarelli N, Borriello F, Dobson R, Oreja-Guevara C, Lin C-J, Zecevic D et al. ( 2022 ) . Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants . Multiple Sclerosis and Related Disorders vol. 64 ,

Foote IF, Jacobs BM, Mathlin G, Watson CJ, Bothongo PL, Waters S, Dobson R, Noyce AJ et al. ( 2022 ) . The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study . Neurobiology of Aging vol. 117 , 222 - 235 .

Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. ( 2022 ) . Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 64 ,

Taylor T, Jacobs B, Giovannoni G, Dobson R ( 2022 ) . 211  The prevalence and characteristics of multiple sclerosis-associated uveitis in UK biobank . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a74.2 - a7a74 .

Jensen M, Jacobs B, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce A ( 2022 ) . Lower lymphocyte count is associated with increased risk of Parkinson’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a94.3 - a9a95 .

Belete D, Jacobs BM, Bestwick JP, Dobson R, Hardy J, Giovannoni G, Lees A, Schrag A et al. ( 2022 ) . Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a7.3 - a7a8 .

Dobson R ( 2022 ) . Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS) . Multiple Sclerosis and Related Disorders

Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R ( 2022 ) . Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals? . Clin Exp Immunol vol. 207 , ( 3 ) 263 - 271 .

Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R ( 2022 ) . Age-specific effects of childhood body mass index on multiple sclerosis risk . Journal of Neurology vol. 269 , ( 9 ) 5052 - 5060 .

Simonet C, Bestwick J, Jitlal M, Waters S, Ben-Joseph A, Marshall CR, Dobson R, Marrium S et al. ( 2022 ) . Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population . JAMA Neurology vol. 79 , ( 4 ) 359 - 369 .

Vukusic S, Dobson R, Bove RM, Hellwig K, Pasquarelli N, Zecevic D, Oreja-Guevara C ( 2022 ) . Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques . Revue Neurologique vol. 178 ,

Dobson R ( 2022 ) . Peripartum disease activity in moderately and severely disabled women with multiple sclerosis . Multiple Sclerosis Journal - Experimental, Translational and Clinical

Dobson R ( 2022 ) . Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study . Frontiers in Neurology

Marshall CR, Noyce AJ, Neligan A, Dobson R ( 2022 ) . Brain health: The hidden casualty of a humanitarian crisis . The Lancet Regional Health - Europe vol. 15 ,

Noyce A ( 2022 ) . No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants . Multiple Sclerosis Journal

Tur C, Dubessy A-L, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M et al. ( 2022 ) . The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021 . Multiple Sclerosis Journal vol. 28 , ( 9 ) 1424 - 1456 .

Bothongo PLK, Jitlal M, Parry E, Waters S, Foote IF, Watson CJ, Cuzick J, Giovannoni G et al. ( 2022 ) . Dementia risk in a diverse population: A single-region nested case-control study in the East End of London . The Lancet Regional Health - Europe vol. 15 ,

Hone L, Giovannoni G, Dobson R, Jacobs BM ( 2022 ) . Predicting Multiple Sclerosis: Challenges and Opportunities . Frontiers in Neurology vol. 12 ,

Dobson R, Chung K ( 2022 ) . Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary . Multiple Sclerosis Journal vol. 28 , ( 2 ) 326 - 327 .

Dobson R, Marshall C, Noyce A ( 2022 ) . Social determinants of neurological disease: tackling inequalities . The Lancet Neurology vol. 21 , ( 2 ) 122 - 123 .

Satukijchai C, Mariano R, Messina S, Sa M, Woodhall MR, Robertson NP, Ming L, Wassmer E et al. ( 2022 ) . Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom . JAMA Network Open vol. 5 , ( 1 )

Geys L, Parciak T, Pirmani A, McBurney R, Schmidt H, Malbaša T, Ziemssen T, Bergmann A et al. ( 2021 ) . The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources . International Journal of MS Care vol. 23 , ( 6 ) 261 - 268 .

Baker D ( 2021 ) . CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis . Multiple Sclerosis and Related Disorders

Dobson R, Craner M, Waddingham E, Miller A, Cavey A, Webb S, Hemingway C, Hobart J et al. ( 2021 ) . OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis . BMJ Open vol. 11 , ( 11 )

Geys L, Dobson R ( 2021 ) . The Multiple Sclerosis Data Alliance Catalogue: enabling web-based discovery of metadata from real-world multiple sclerosis data sources . International Journal of MS Care

Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G ( 2021 ) . COVID-19 vaccine response in people with multiple sclerosis . Annals of Neurology

Huxford B, Haque T, Joseph AB, Simonet C, Gallagher D, Budu C, Dobson R, Noyce A ( 2021 ) . Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity . Movement Disorders vol. 37 , ( 2 ) 427 - 428 .

Foote I, Jacobs B, Watson C, Bothongo P, Waters S, Dobson R, Noyce A, Bhui K et al. ( 2021 ) . W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH . European Neuropsychopharmacology vol. 51 , e159 - e159 .

Camera V, Messina S, Elhadd KT, Sanpera-Iglesias J, Mariano R, Hacohen Y, Dobson R, Meletti S et al. ( 2021 ) . Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 1 ) 101 - 111 .

Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R ( 2021 ) . Age-specific effects of childhood Body Mass Index on multiple sclerosis risk .

Yam C, Rog D, Ford H, Murray K, Hughes S, Pearson O, Brex P, Dobson R ( 2021 ) . UK variance in DMT advice and prescribing in MS and pregnancy: impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines . Multiple Sclerosis and Related Disorders103272 - 103272 .

Dobson R ( 2021 ) . Differing Impact of DMT on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately? . Neurology

Kuri A, Jacobs BM, Leddy S, Schmierer K, Turner B, Allen-Philbey K, Stennett A, Giovannoni G et al. ( 2021 ) . Evaluation of remote assessments for multiple sclerosis in an in-home setting . Multiple Sclerosis and Related Disorders vol. 54 ,

Leavitt VM, Dobson R, Svennigsson A ( 2021 ) . Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress . Neurology vol. 96 , ( 23 ) 1067 - 1068 .

Garjani A, Hunter R, Law G, Middleton R, Tuite-Dalton KA, Dobson R, Ford DV, Hughes S et al. ( 2021 ) . Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register . Multiple Sclerosis Journal

Jacobs B, Dobson R ( 2021 ) . Ethnicity and multiple sclerosis – moving beyond preconceptions . Advances in Clinical Neuroscience & Rehabilitation vol. 20 ,

Jacobs BM, Noyce AJ, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2021 ) . Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study . Neurology Neuroimmunology & Neuroinflammation vol. 8 , ( 4 )

Dobson R, ALLEN-PHILBEY K, Giovannoni G, Baker D, Schmierer K ( 2021 ) . Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis . Multiple Sclerosis and Related Disorders

Garjani A, Middleton RM, Hunter R, Tuite-Dalton KA, Coles A, Dobson R, Duddy M, Hughes S et al. ( 2021 ) . COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies . Multiple Sclerosis and Related Disorders vol. 52 , 102939 - 102939 .

Taylor TRP, Galloway J, Davies R, Hyrich K, Dobson R ( 2021 ) . Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis . Neurology, Neuroimmunology and Neuroinflammation vol. 8 , ( 3 )

Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K ( 2021 ) . Treatment of Women with Multiple Sclerosis Planning Pregnancy . Current Treatment Options in Neurology vol. 23 , ( 4 )

Jitlal M, Amirthalingam G, Karania T, Parry E, Neligan A, Dobson R, Noyce A, MARSHALL C ( 2021 ) . The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017 . Journal of Alzheimer's Disease

Dobson R, Fenton N, Hartmann M ( 2021 ) . Current Review and Next Steps for Artificial intelligence in Multiple Sclerosis risk research . Computers in Biology and Medicine

Dobson R, Hellwig K ( 2021 ) . Use of disease-modifying drugs during pregnancy and breastfeeding . Current Opinion in Neurology vol. 34 , ( 3 ) 303 - 311 .

Foote IF, Jacobs BM, Mathlin G, Watson CJ, Bothongo PL, Waters S, Dobson R, Noyce AJ et al. ( 2021 ) . The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study .

Jensen MP, Jacobs BM, Dobson R, Bandres‐Ciga S, Blauwendraat C, Schrag A, Noyce AJ, Consortium TIPDG ( 2021 ) . Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease . Annals of Neurology vol. 89 , ( 4 ) 803 - 812 .

Hone L, Jacobs B, Noyce A, Dobson R ( 2021 ) . Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 764 - 765 .

Stennett A, Allen-Philbey K, Begum T, Johnson A, Dobson R, Giovannoni G, Gnanapavan S, Marta M et al. ( 2021 ) . An evaluation of remote monitoring in people with MS during the COVID-19 pandemic . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 268 - 269 .

Bove R, Pasquarelli N, Borriello F, Dobson R, Hellwig K, McElrath T, Oreja-Guevara C, Wei W et al. ( 2021 ) . B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO) . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 583 - 584 .

Huxford B, Haque T, Joseph A, Simonet C, Gallagher D, Budu C, Dobson R, Noyce A ( 2021 ) . HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes . MOVEMENT DISORDERS . vol. 36 , S452 - S452 .

Dobson R, Bove R, Borriello F, Craveiro L, Ferreira G, Hellwig K, McElrath T, Pasquarelli N et al. ( 2021 ) . Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 554 - 555 .

Ostrem B, Anderson A, Conway S, Oh J, Sadovnick D, Dobson R, Graham E, Jacobs D et al. ( 2021 ) . Pregnancy outcomes and peripartum disease activity in moderately and severely disabled women with MS . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 246 - 247 .

Hellwig K, Pasquarelli N, Borriello F, Bove R, Dobson R, Oreja-Guevara C, Vukusic S, Wei W et al. ( 2021 ) . Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study) . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 564 - 565 .

Vickaryous N, Asardag AN, Chance R, Jones M, Bestwick J, Shah SN, George K, Schmierer K et al. ( 2021 ) . Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy . MULTIPLE SCLEROSIS JOURNAL vol. 27 , ( 2_SUPPL ) 775 - 776 .

Simpson-Yap S, Pirmani A, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N, Kalincik T et al. ( 2021 ) . Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 741 - 743 .

Hartmann M, Fenton N, Dobson R ( 2021 ) . Using Bayesian networks to understand multiple sclerosis risk factor interactions . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 375 - 375 .

Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R ( 2020 ) . Remote testing of vitamin D levels across the UK MS population—A case control study . PLOS ONE vol. 15 , ( 12 )

Jacobs BM, Smets I, Giovannoni G, Noyce A, Jokubaitis V, Dobson R ( 2020 ) . Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis . Multiple Sclerosis Journal vol. 27 , ( 8 ) 1311 - 1312 .

Bothongo PL, Jitlal M, Parry E, Foote IF, Waters S, Dobson R, Noyce AJ, Bestwick JP et al. ( 2020 ) . Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London . Alzheimer's & Dementia vol. 16 , ( S10 )

Thomson A, Dobson R, Baker D, Giovannoni G ( 2020 ) . Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families . Multiple Sclerosis and Related Disorders vol. 47 ,

Auger SD, Jacobs BM, Dobson R, Marshall CR, Noyce AJ ( 2020 ) . Big data, machine learning and artificial intelligence: a neurologist’s guide . Practical Neurology vol. 21 , ( 1 ) 4 - 11 .

Auger S, Jacobs B, Dobson R, MARSHALL C, Noyce A ( 2020 ) . Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide . Practical Neurology

Jacobs B, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, International Parkinson’s Disease Genomics Consortium (IPDGC) et al. ( 2020 ) . Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank . Journal of Neurology, Neurosurgery and Psychiatry vol. 91 , 1046 - 1054 .

Leddy S, Dobson R ( 2020 ) . Multiple sclerosis . Medicine vol. 48 , ( 9 ) 588 - 594 .

Evangelou N, Garjani A, dasNair R, Hunter R, Tuite-Dalton KA, Craig EM, Rodgers WJ, Coles A et al. ( 2020 ) . Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register . Journal of Neurology Neurosurgery & Psychiatry vol. 92 , ( 1 ) 107 - 109 .

Dobson R, Giovannoni G, Cuzick J ( 2020 ) . Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment . International Journal of Epidemiology

Dobson R ( 2020 ) . MS, pregnancy and COVID-19 . Multiple Sclerosis Journal

Jacobs B, Taylor T, Awad A, Baker D, Giovannoni G, Noyce A, Dobson R ( 2020 ) . Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis . Brain Communications

Peeters LM, Parciak T, Walton C, Geys L, Moreau Y, De Brouwer E, Raimondi D, Pirmani A et al. ( 2020 ) . COVID-19 in people with multiple sclerosis: A global data sharing initiative . Mult Scler1352458520941485 - 1352458520941485 .

Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J et al. ( 2020 ) . Protecting people with multiple sclerosis through vaccination . Practical Neurology

Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R et al. ( 2020 ) . Sex effects across the lifespan in women with multiple sclerosis . Therapeutic Advances in Neurological Disorders vol. 13 ,

Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R ( 2020 ) . Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom . BMC Public Health vol. 20 , ( 1 )

Dobson R, Jokubaitis V, Giovannoni G ( 2020 ) . Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis . Multiple Sclerosis and Related Disorders

Taylor TR, Jacobs BM, Giovannoni G, Petrushkin H, Dobson R ( 2020 ) . Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study . Multiple Sclerosis and Related Disorders vol. 43 ,

Dobson R, Mowry EM ( 2020 ) . Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis . Neurology vol. 94 , ( 18 ) 769 - 770 .

Leddy S, Jacobs B, Giovannoni G, Dobson R ( 2020 ) . Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study (3946) . Neurology vol. 94 , ( 15_supplement )

Jacobs B, Giovannoni G, Dobson R ( 2020 ) . Environmental exposures associated with Multiple Sclerosis: a UK Biobank study (474) . Neurology vol. 94 , ( 15_supplement )

Dobson R, Yam C ( 2020 ) . Pregnancy in multiple sclerosis: influence on disease trajectory . Advances in Clinical Neuroscience & Rehabilitation vol. 19 , ( 3 ) 15 - 16 .

Dobson R, Jacobs B, Giovannoni G, Cuzick J ( 2020 ) . Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors . Multiple Sclerosis Journal

Jokubaitis VG, Dobson R ( 2020 ) . Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis . Neurology vol. 94 , ( 10 ) 455 - 456 .

Jokubaitis V, Dobson R ( 2020 ) . Family planning is the second most relevant factor for treatment decisions after disease activity . Multiple Sclerosis Journal

Dobson R, Jitlal M, Marshall CR, Noyce AJ, Robson J, Cuzick J, Giovannoni G ( 2020 ) . Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk . Annals of Neurology vol. 87 , ( 4 ) 599 - 608 .

Dobson R, Noyce A, Giovannoni G, jacobs B ( 2020 ) . BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study . Neurology, Neuroimmunology and Neuroinflammation

Garjani A, Hunter R, Nicholas R, Middleton R, Tuite-Dalton K, Coles A, Dobson R, Duddy M et al. ( 2020 ) . Anxiety affects the general well-being of people with ms during the COVID-19 pandemic more than the infection itself . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 65 - 65 .

Leddy S, Jacobs B, Giovannoni G, Dobson R ( 2020 ) . Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study . NEUROLOGY . vol. 94 ,

Garjani A, Evangelou N, Das Nair R, Hunter R, Tuite-Dalton K, Coles A, Dobson R, Duddy M et al. ( 2020 ) . COVID-19 in people with MS: a large community-based study of the UK MS register . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 46 - 47 .

Taylor T, Luis J, Dobson R, Petrushkin H ( 2020 ) . Demographics of multiple sclerosis associated uveitis at moorfields eye hospital . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 484 - 484 .

Taylor T, Galloway J, Adam R, Hyrich K, Dobson R ( 2020 ) . Demyelinating events following initiation of anti-tnfα therapy in the british society for rheumatology biologics registry in rheumatoid arthritis . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 241 - 241 .

Jacobs B, Giovannoni G, Dobson R ( 2020 ) . Environmental exposures associated with Multiple Sclerosis: a UK Biobank study . NEUROLOGY . vol. 94 ,

Jacobs B, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2020 ) . Gene-environment interactions in multiple sclerosis: a uk biobank study . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 367 - 367 .

Belete D, Jacobs B, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls M et al. ( 2020 ) . Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank . MOVEMENT DISORDERS . vol. 35 , S74 - S74 .

Leddy S, Jacobs BM, Giovannoni G, Dobson R ( 2020 ) . To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association . EUROPEAN JOURNAL OF NEUROLOGY . vol. 27 , 981 - 981 .

Vickaryous N, Garjani A, Jacobs B, Jitlal M, Middleton R, Das Nair R, Tuite-Dalton K, Hunter R et al. ( 2020 ) . Vitamin D levels in the UK MS population and COVID-19 susceptibility . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 55 - 55 .

Jacobs BM, Giovannoni G, Cuzick J, Dobson R ( 2019 ) . Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors . medRxiv19007450 - 19007450 .

DOBSON R ( 2019 ) . Visibility and representation of women in multiple sclerosis research . Neurology

Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA ( 2019 ) . UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines . Pract Neurol

Dobson R, Jitlal M, Marshall C, Noyce A, Giovannoni G ( 2019 ) . Obesity is not associated with MS in a socially and ethnically diverse population . MULTIPLE SCLEROSIS JOURNAL . vol. 25 , 49 - 49 .

Vickaryous N, Jitlal M, Middleton R, Giovannoni G, Dobson R ( 2019 ) . Vitamin D levels in the UK MS population . MULTIPLE SCLEROSIS JOURNAL . vol. 25 , 449 - 450 .

in IW ( 2018 ) . Gender Inequities in the Multiple Sclerosis Community: A Call for Action . Annals of Neurology vol. 84 , ( 6 ) 958 - 959 .

Dobson R ( 2018 ) . Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution' . Mult Scler1352458518807053 - 1352458518807053 .

Dobson R, Giovannoni G ( 2018 ) . Multiple Sclerosis - a review . Eur J Neurol vol. 26 , 27 - 40 .

Thomson A, Aldam R, Giovannoni G . Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families .

Dobson R, Cock HR, Brex P, Giovannoni G ( 2017 ) . Vitamin D supplementation . Practical Neurology vol. 18 , ( 1 )

Dobson R, Kuhle J, Middeldorp J, Giovannoni G ( 2017 ) . Epstein-Barr-negative MS: a true phenomenon? . Neurol Neuroimmunol Neuroinflamm vol. 4 , ( 2 ) e318 - e318 .

Middleton RM, Rodgers WJ, Giovannoni G, Schmierer K, Dobson R, Allen-Philbey K, Patterson A, Akbari A et al. ( 2017 ) . A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register . MULTIPLE SCLEROSIS JOURNAL . vol. 23 , 153 - 154 .

Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K, Chard D, Giovannoni G ( 2016 ) . A Risk Score for Predicting Multiple Sclerosis . PLoS One vol. 11 , ( 11 ) Article 0164992 , e0164992 - e0164992 .

Binks S, Dobson R ( 2016 ) . Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease . Curr Osteoporos Rep vol. 14 , ( 5 ) 199 - 210 .

DE Collins C, Ivry B, Bowen JD, Cheng EM, Dobson R, Goodin DS, Lechner-Scott J, Kappos L et al. ( 2016 ) . A comparative analysis of Patient-Reported Expanded Disability Status Scale tools . Multiple Sclerosis Journal vol. 22 , ( 10 ) 1349 - 1358 .

Dobson R, Alvares D ( 2016 ) . The difficulties with vitamin B12 . Practical Neurology vol. 16 , ( 4 )

Topping J, Dobson R, Lapin S, Maslyanskiy A, Kropshofer H, Leppert D, Giovannoni G, Evdoshenko E ( 2016 ) . The effects of intrathecal rituximab on biomarkers in multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 6 , 49 - 53 .

Disanto G, Adiutori R, Dobson R, Martinelli V, Costa GD, Runia T, Evdoshenko E, Thouvenot E et al. ( 2016 ) . Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY vol. 87 , ( 2 ) 126 - 129 .

Binks S, Dobson R ( 2015 ) . Established, new and future disease modifying therapies for MS . Progress in Neurology and Psychiatry vol. 19 , ( 5 ) 27 - 35 .

Davis A, Dobson R, Kaninia S, Giovannoni G, Schmierer K ( 2015 ) . Atraumatic needles for lumbar puncture: why haven't neurologists changed? . Practical Neurology vol. 16 , ( 1 )

Disanto G, Adiutori R, Dobson R, Martinelli V, Costa GD, Runia T, Evdoshenko E, Thouvenot E et al. ( 2015 ) . Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome . Journal of Neurology Neurosurgery & Psychiatry vol. 87 , ( 2 )

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier U-C et al. ( 2015 ) . Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study . Multiple Sclerosis Journal vol. 21 , ( 8 ) 1013 - 1024 .

Leddy S, Fowler AJ, Giovanonni G, Dobson R ( 2014 ) . DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS . Journal of Neurology Neurosurgery & Psychiatry . vol. 85 , e4 - e4 .

Cooper R, Doshi A, Harris P, Sivagnanasundaram J, Wells G, Barritt A, Aram J, Giovannoni G et al. ( 2014 ) . IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA? . Journal of Neurology Neurosurgery & Psychiatry . vol. 85 , e4 - e4 .

Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu C-H, Dobson R et al. ( 2014 ) . Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome . Journal of Neurology Neurosurgery & Psychiatry vol. 86 , ( 3 )

Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Kuhle J, Giovannoni G ( 2014 ) . The Refinement of Genetic Predictors of Multiple Sclerosis . PLOS ONE vol. 9 , ( 5 )

Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R ( 2014 ) . A service development study of the assessment and management of fracture risk in Parkinson’s disease . Journal of Neurology vol. 261 , ( 6 ) 1153 - 1159 .

Dobson R, Topping J, Chard D, Schmierer K, Smith P, Ramagopalan S, Giovannoni G ( 2014 ) . A Multivariate Risk Calculator for Multiple Sclerosis and Study of an Endophenotype in Siblings of People with Multiple Sclerosis (S34.002) . Neurology vol. 82 , ( 10_supplement )

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . Bone health in Parkinson's disease: a systematic review and meta-analysis . Journal of Neurology Neurosurgery & Psychiatry vol. 85 , ( 10 )

Shribman SE, Torsney K, Noyce AJ, Giovannoni G, Fearnley J, Dobson R ( 2014 ) . A service development study of the assessment and management of fracture risk in Parkinson's disease . MOVEMENT DISORDERS . vol. 29 , S192 - S192 .

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . A systematic review and meta-analysis of fracture risk in Parkinson's disease . MOVEMENT DISORDERS . vol. 29 , S551 - S551 .

Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G ( 2014 ) . Assessing treatment response to interferon-β Is there a role for MRI? . NEUROLOGY vol. 82 , ( 3 ) 248 - 254 .

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . Bone health in Parkinson's disease: A systematic review and meta-analysis . MOVEMENT DISORDERS . vol. 29 , S551 - S551 .

Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Gobbi C, Kuhle J, Giovannoni G ( 2014 ) . Genetic predictors of multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 20 , 253 - 253 .

Raffel J, Dobson R, Gafson A, Mattoscio M, Muraro P, Giovannoni G ( 2013 ) . Multiple sclerosis therapy and Epstein–Barr virus antibody titres . Multiple Sclerosis and Related Disorders vol. 3 , ( 3 ) 372 - 374 .

Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G ( 2013 ) . Assessing treatment response to interferon-&bgr; . Neurology vol. 82 , ( 3 ) 248 - 254 .

Davis A, Dobson R, Kaninia S, Espasandin M, Berg A, Giovannoni G, Schmierer K ( 2013 ) . Change practice now! Using atraumatic needles to prevent post lumbar puncture headache . European Journal of Neurology vol. 21 , ( 2 ) 305 - 311 .

Leddy S, Hadavi S, Mc Carren A, Giovanonni G, Dobson R ( 2013 ) . A NOVEL INTERNET–BASED METHOD OF CAPTURING OUTCOMES IN MULTIPLE SCLEROSIS . Journal of Neurology Neurosurgery & Psychiatry vol. 84 , ( 11 )

Hadavi S, Giovannoni G, Dobson R ( 2013 ) . A SERVICE DEVELOPMENT AUDIT OF FAMPRIDINE USE IN MS . Journal of Neurology Neurosurgery & Psychiatry vol. 84 , ( 11 )

Hadavi S, Shribman S, Nagy A, Acharya S, Fearnley J, Dobson R, Lees A, Giovannoni G et al. ( 2013 ) . THE BRADYKINESIA–AKINESIA INCOORDINATION TEST: A SIMPLE OBJECTIVE TEST IN MULTIPLE SCLEROSIS . Journal of Neurology Neurosurgery & Psychiatry vol. 84 , ( 11 )

Dobson R, McMillan A, Kung K, Thom M, Davis A, Simister R, Giovannoni G, Gnanapavan S ( 2013 ) . THINK OUTSIDE THE BOX, COLLAPSE THE BOX, AND TAKE A SHARP KNIFE TO IT! . Journal of Neurology Neurosurgery & Psychiatry vol. 84 , ( 11 )

Dobson R, Topping J, Ramagopalan S, Giovannoni G ( 2013 ) . TOWARDS AN ENDOPHENOTYPE IN MULTIPLE SCLEROSIS . Journal of Neurology Neurosurgery & Psychiatry vol. 84 , ( 11 )

James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV ( 2013 ) . The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis . Mult Scler vol. 19 , ( 12 ) 1571 - 1579 .

Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R ( 2013 ) . Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis . J Neurol vol. 260 , ( 10 ) 2505 - 2510 .

Puentes F, Topping J, Kuhle J, van der Star BJ, Douiri A, Giovannoni G, Baker D, Amor S et al. ( 2013 ) . Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis . Journal of Neurology Neurosurgery & Psychiatry vol. 85 , ( 3 )

Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU et al. ( 2013 ) . Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases . PLOS ONE vol. 8 , ( 9 )

Dobson R, Giovannoni G ( 2013 ) . Bone health in multiple sclerosis: should we be doing more? . Neurodegenerative Disease Management vol. 3 , ( 5 ) 401 - 403 .

Evdoshenko E, Maslyanskiy A, Lapin S, Zaslavsky L, Dobson R, Totolian A, Skoromets A, Bar-Or A ( 2013 ) . Dynamics of B‐Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone . International Scholarly Research Notices vol. 2013 , ( 1 )

Dobson R, Ramagopalan S, Davis A, Giovannoni G ( 2013 ) . Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude . J Neurol Neurosurg Psychiatry vol. 84 , ( 8 ) 909 - 914 .

Hadavi S, Baker MD, Dobson R ( 2013 ) . Sustained-release fampridine in Multiple Sclerosis . Multiple Sclerosis and Related Disorders vol. 3 , ( 1 ) 17 - 21 .

Dobson R, Giovannoni G ( 2013 ) . Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis . J Neurol vol. 260 , ( 5 ) 1272 - 1285 .

Dobson R, Yarnall A, Noyce AJ, Giovannoni G ( 2013 ) . Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes . Pract Neurol vol. 13 , ( 2 ) 70 - 79 .

Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV ( 2013 ) . Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine . PLOS ONE vol. 8 , ( 4 )

Dobson R, Giovannoni G, Ramagopalan S ( 2013 ) . The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude . J Neurol Neurosurg Psychiatry vol. 84 , ( 4 ) 427 - 432 .

Dobson R, Leddy SG, Gangadharan S, Giovannoni G ( 2013 ) . Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems . BMJ Open vol. 3 , ( 3 )

Dobson R, Topping J, Davis A, Thompson E, Giovannoni G ( 2013 ) . Cerebrospinal fluid and urinary biomarkers in multiple sclerosis . Acta Neurologica Scandinavica vol. 128 , ( 5 ) 321 - 327 .

Dobson R, Ramagopalan SV, Giovannoni G ( 2013 ) . Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics? . Expert Rev Neurother vol. 13 , ( 3 ) 235 - 237 .

Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV ( 2013 ) . The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis . Mult Scler vol. 19 , ( 2 ) 162 - 166 .

Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R ( 2013 ) . A novel internet-based method of capturing outcomes in multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 19 , 357 - 358 .

Dobson R, Ramagopalan S, Davis A, Giovannoni G ( 2013 ) . Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude . Journal of Neurology, Neurosurgery and Psychiatry vol. 84 , ( 8 ) 909 - 914 .

Dobson R, Topping J, Giovannoni G ( 2013 ) . Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers . J Med Virol vol. 85 , ( 1 ) 128 - 131 .

Kuhle J, Dobson R, Bestwick JP, Topping J, Dalla Costa G, Khademi M, Sombekke M, Killestein J et al. ( 2013 ) . Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS . MULTIPLE SCLEROSIS JOURNAL . vol. 19 , 33 - 34 .

Dobson R, Giovannoni G, Ramagopalan S ( 2013 ) . The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude . Journal of Neurology, Neurosurgery and Psychiatry vol. 84 , ( 4 ) 427 - 432 .

Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . Bone health and multiple sclerosis . Mult Scler vol. 18 , ( 11 ) 1522 - 1528 .

Dobson R, Ramagopalan S, Giovannoni G, Bazelier MT, de Vries F ( 2012 ) . Risk of fractures in patients with multiple sclerosis . Neurology vol. 79 , ( 18 ) 1934 - 1935 .

Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV ( 2012 ) . Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine . PLoS ONE vol. 7 , ( 9 )

Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . The effect of gender in clinically isolated syndrome (CIS): a meta-analysis . Mult Scler vol. 18 , ( 5 ) 600 - 604 .

Dobson R ( 2012 ) . Urine: An under-studied source of biomarkers in multiple sclerosis? . Multiple Sclerosis and Related Disorders vol. 1 , ( 2 ) 76 - 80 .

Dobson R, Rudick RA, Giovannoni G ( 2012 ) . CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON β: A SYSTEMATIC REVIEW AND META-ANALYSIS . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Davis A, Dobson R, Espasandin M, Giovannoni G, Schmierer K ( 2012 ) . Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 237 - 238 .

Dobson R, Meier UC, Schmierer K, Giovannoni G ( 2012 ) . DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK? . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Disanto G, Sandve GK, Berlanga-Taylor AJ, Morahan JM, Dobson R, Giovannoni G, Ramagopalan SV ( 2012 ) . Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells . PLOS ONE vol. 7 , ( 3 ) Article ARTN e32281 ,

Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . Osteoporosis and fracture risk in multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 243 - 244 .

Raffel J, Dobson R, Giovannoni G ( 2012 ) . THE EFFECT OF NATALIZUMAB AND INTERFERON-β ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Topping J, Evdoshenko E, Dobson R, Lapin S, Maslyanskiy A, Giovannoni G ( 2012 ) . The effects of intrathecal rituximab on biomarkers in MS . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 268 - 268 .

Dobson R, Topping J, Davis A, Giovannoni G ( 2012 ) . Urinary and CSF biomarkers in multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 502 - 503 .

Dobson R, Giovannoni G ( 2012 ) . WHY CAN'T I WIN ANY MORE? . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,

Dobson R, Lawden M ( 2011 ) . Melanoma associated retinopathy and how to understand the electroretinogram . Pract Neurol vol. 11 , ( 4 ) 234 - 239 .

Maghzi A-H, Marta M, Bosca I, Etemadifar M, Dobson R, Maggiore C, Giovannoni G, Meier U-C ( 2011 ) . Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection? . Pathophysiology vol. 18 , ( 1 ) 13 - 20 .

Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV ( 2011 ) . Smoking and Multiple Sclerosis: An Updated Meta-Analysis . PLOS ONE vol. 6 , ( 1 ) Article e16149 ,

Dobson R, Meier UC, Schmierer K, Giovannoni G ( 2011 ) . Do siblings have markers of multiple sclerosis risk? . MULTIPLE SCLEROSIS JOURNAL vol. 17 , S86 - S86 .

Meier UC, Giovannoni G ( 2011 ) . More to come: humoral immune responses in MS . Journal of Neuroimmunology vol. 240-241 , 13 - 21 .

Dobson R, Meier UC, Marta M, Ramagopalan S, Giovannoni G ( 2011 ) . Vitamin D deficiency - do we follow our own advice? . CLINICAL MEDICINE vol. 11 , ( 6 ) 521 - 523 .

Dobson R, Feldmann M, Thompson AJ, Giovannoni G, Miller DH, Thompson EJ, Palmer HE, Miller RF ( 2010 ) . INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 81 , E57 - E57 .

Dobson R, Lawden M ( 2010 ) . CP1 Darkness visible . Journal of Neurology Neurosurgery & Psychiatry vol. 81 , ( 11 )

Ramagopalan SV, Dobson R, Meier UC, Giovannoni G ( 2010 ) . Multiple sclerosis: risk factors, prodromes, and potential causal pathways . Lancet Neurol vol. 9 , ( 7 ) 727 - 739 .

Dobson R, Miller RF, Palmer HE, Feldmann M, Thompson EJ, Thompson AJ, Miller DH, Giovannoni G ( 2010 ) . Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis . J Neuroimmunol vol. 220 , ( 1-2 ) 99 - 103 .